These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 17896859)
41. Industry sponsored research. Klotz LH Can J Urol; 2004 Aug; 11(4):2312-3. PubMed ID: 15380051 [No Abstract] [Full Text] [Related]
42. Conflict of interest, an unspoken reality in science. Danda D Int J Rheum Dis; 2014 Feb; 17(2):131. PubMed ID: 24576269 [No Abstract] [Full Text] [Related]
43. Falling out with pharma. Whitehead S Lancet; 2013 Mar; 381(9872):1096-7. PubMed ID: 23540851 [No Abstract] [Full Text] [Related]
44. Drug companies and publishers set out 10 steps to enhance credibility of industry sponsored trials. Roehr B BMJ; 2012 May; 344():e3767. PubMed ID: 22641830 [No Abstract] [Full Text] [Related]
45. Medical partisans? Why doctors need conflicting interests. Healy D Aust N Z J Psychiatry; 2012 Aug; 46(8):704-7. PubMed ID: 22848058 [No Abstract] [Full Text] [Related]
46. Conflicts of Interest: can a physician serve two masters? Greenberg RD Clin Dermatol; 2012; 30(2):160-73. PubMed ID: 22330659 [TBL] [Abstract][Full Text] [Related]
47. Regarding 'Is PHARMAC's sole-supply tendering policy harming the health of New Zealanders?' editorial. Gray B N Z Med J; 2005 May; 118(1215):U1481; discussion U1481. PubMed ID: 15915196 [No Abstract] [Full Text] [Related]
48. Physicians and the pharmaceutical industry. Breen KJ; Rogers W Intern Med J; 2006 Jan; 36(1):66-7; author reply 68. PubMed ID: 16409319 [No Abstract] [Full Text] [Related]
49. Editorial: premature publishing and over-fragmentation. Tarzia G ChemMedChem; 2013 Jan; 8(1):6-7. PubMed ID: 23281336 [No Abstract] [Full Text] [Related]
50. Focus on the funding and production of evidence rather than its publication. Sheldon T PLoS Med; 2005 Jul; 2(7):e222. PubMed ID: 16033316 [No Abstract] [Full Text] [Related]
51. Bidirectional conflicts of interest involving industry and medical journals: who will champion integrity? Lanier WL Mayo Clin Proc; 2009 Sep; 84(9):771-5. PubMed ID: 19720773 [No Abstract] [Full Text] [Related]
52. Conflicts of interest in data monitoring of industry versus publicly financed clinical trials. Lachin JM Stat Med; 2004 May; 23(10):1519-21. PubMed ID: 15122730 [TBL] [Abstract][Full Text] [Related]
53. Little fish are less likely to take the bait. Marcovitch H PLoS Med; 2005 Jul; 2(7):e221. PubMed ID: 16033315 [No Abstract] [Full Text] [Related]
54. Growing pains in AIDS drug development. Herrera S Nat Biotechnol; 2004 Oct; 22(10):1194. PubMed ID: 15470440 [No Abstract] [Full Text] [Related]
55. The ethics of pharmaceutical industry gift-giving: the role of a professional association. Morin K; Morse LJ Am J Bioeth; 2003; 3(3):54-5. PubMed ID: 14594494 [No Abstract] [Full Text] [Related]
56. The right to a trial: Should dying patients have access to experimental drugs? Groopman J New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539 [No Abstract] [Full Text] [Related]
57. Medical advertisements in medical journals: the case against. Chisholm CD; Gentile NT; Gerhardt RT; Hauswald M; Mycyk MB; Sinert R; Sokolove PE Acad Emerg Med; 2009 Oct; 16(10):981-3. PubMed ID: 19799575 [No Abstract] [Full Text] [Related]
58. Ethical issues in the relationships involving medicine and industry: evolving problems require evolving. Komesaroff P Intern Med J; 2005 Apr; 35(4):203-5. PubMed ID: 15836496 [No Abstract] [Full Text] [Related]
59. Challenges in science and academic-industry interactions. Eisman JA; Lorenzo JA J Bone Miner Res; 2007 Nov; 22(11):1654-5. PubMed ID: 17931099 [No Abstract] [Full Text] [Related]
60. Giving and receiving of gifts between pharmaceutical and medical specialists in Australia. Wilson A Intern Med J; 2006 Dec; 36(12):795-6; author reply 796-7. PubMed ID: 17096745 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]